BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
39 hedge funds and large institutions have $8.24M invested in BRAINSTORM CELL THERAPUTC in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 0.59% → 0.63% (+0.03%)
95% less call options, than puts
Call options by funds: $107K | Put options by funds: $2.22M
Holders
39
Holding in Top 10
–
Calls
$107K
Puts
$2.22M
Top Buyers
| 1 | +$338K | |
| 2 | +$293K | |
| 3 | +$293K | |
| 4 |
Renaissance Technologies
New York
|
+$284K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$101K |
Top Sellers
| 1 | -$625K | |
| 2 | -$66K | |
| 3 | -$64.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$63K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
-$16.8K |